Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics

References

• AokiRTanakaS1998MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinomaDis Colon Rectum41101262729788390
   PubMed Web of Science ®Google Scholar
• ApteRModiMMasonsonHfor the Macugen AMD Study Group2007Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degenerationOphthalmology114917021217509689
   PubMed Web of Science ®Google Scholar
• BanderNHMilowskyMINanusDM2005Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancerJ Clin Oncol2321459160115837970
   PubMed Web of Science ®Google Scholar
• BatesPJKahlonJBThomasSD1999Antiproliferative activity of G-rich oligonucleotides correlates with protein bindingJ Biol Chem27437263697710473594
   PubMed Web of Science ®Google Scholar
• BeigelmanLMcSwiggenJADraperKG1995Chemical modification of hammerhead ribozymes. Catalytic activity and nuclease resistanceJ Biol Chem270432570287592749
   PubMed Web of Science ®Google Scholar
• BerchuckAKamelAWhitakerR1990Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancerCancer Res50134087911972347
   PubMed Web of Science ®Google Scholar
• BoomerRMLewisSDHealyJM2005Conjugation to polyethylene glycol polymer promotes aptamer biodistribution to healthy and inflamed tissuesOligonucleotides1531839516201906
   PubMedGoogle Scholar
• BorsiLCarnemollaBNicoloG1992Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissuesInt J Cancer525688921385335
   PubMed Web of Science ®Google Scholar
• BostwickDGPacelliABluteM1998Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 casesCancer82112256619610707
   PubMed Web of Science ®Google Scholar
• BrossartPSchneiderADillP2001The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytesCancer Res611868465011559560
   PubMed Web of Science ®Google Scholar
• BunkaDHStockleyPG2006Aptamers come of age – at lastNat Rev Microbiol485889616845429
   PubMed Web of Science ®Google Scholar
• BurjonrappaSCReddimasuSNawazZ2007Mucin expression profile in Barrett’s, dysplasia, adenocarcinoma sequence in the esophagusIndian J Cancer4411517401217
   PubMedGoogle Scholar
• BurmeisterPELewisSDSilvaRF2005Direct in vitro selection of a 2′-O-methyl aptamer to VEGFChem Biol121253315664512
   PubMedGoogle Scholar
• CassidayLAMaherLJ3rd2001In vivo recognition of an RNA aptamer by its transcription factor targetBiochemistry4082433811327864
   PubMed Web of Science ®Google Scholar
• CerchiaLDucongéFPestourieC2005Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinasePLoS Biol34e12315769183
   PubMed Web of Science ®Google Scholar
• ChenCHChernisGAHoangVQ2003Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3Proc Natl Acad Sci USA1001692263112874383
   PubMed Web of Science ®Google Scholar
• ChengJTeplyBASherifiI2007Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryBiomaterials2858697617055572
   PubMed Web of Science ®Google Scholar
• Chiquet-EhrismannR2004TenascinsInt J Biochem Cell Biol3669869015094113
   PubMed Web of Science ®Google Scholar
• ChristianSPilchJAkermanME2003Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vesselsJ Cell Biol1634871814638862
   PubMed Web of Science ®Google Scholar
• ChuTCTwuKYEllingtonAD2006Aptamer mediated siRNA deliveryNucleic Acids Res3410e7316740739
   PubMed Web of Science ®Google Scholar
• CoxJCHayhurstAHesselberthJ2002Automated selection of aptamers against protein targets translated in vitro: from gene to aptamerNucleic Acids Res3020e10812384610
   PubMed Web of Science ®Google Scholar
• DapićVAbdomerovićVMarringtonR2003Biophysical and biological properties of quadruplex oligodeoxyribonucleotidesNucleic Acids Res318209710712682360
   PubMed Web of Science ®Google Scholar
• DapićVBatesPJTrentJO2002Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modificationsBiochemistry411136768511888284
   PubMed Web of Science ®Google Scholar
• DerenziniM2000The AgNORsMicron3121172010588056
   PubMed Web of Science ®Google Scholar
• DerenziniMSirriVTrereD1995The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cellsLab Invest7344975027474921
   PubMed Web of Science ®Google Scholar
• de SmidtPCLe DoanTde FalcoS1991Association of antisense oligonucleotides with lipoproteins prolongs the plasma half-life and modifies the tissue distributionNucleic Acids Res191746957001891360
   PubMed Web of Science ®Google Scholar
• DougallWCQianXGreeneMI1993Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapyJ Cell Biochem53161737901229
   PubMed Web of Science ®Google Scholar
• DouganHLysterDMVoCV2000Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in bloodNucl Med Biol2732899710832086
   PubMed Web of Science ®Google Scholar
• DroletDWNelsonJTuckerCE2000Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeysPharm Res171215031011303960
   PubMed Web of Science ®Google Scholar
• DybaMTarasovaNIMichejdaCJ2004Small molecule toxins targeting tumor receptorsCurr Pharm Des101923113415279611
   PubMed Web of Science ®Google Scholar
• EllingtonADCoxJCHayhurstA2005Automated in vitro selection and microarray applications for functional RNA sequencesThe RNA World3rd EdCold Spring Harbor, New YorkCold Spring Harbor Laboratory Press683719
   Google Scholar
• EllingtonADSzostakJW1990In vitro selection of RNA molecules that bind specific ligandsNature3466287818221697402
   PubMed Web of Science ®Google Scholar
• EricksonHPBourdonMA1989Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumorsAnnu Rev Cell Biol571922480799
   PubMedGoogle Scholar
• FarokhzadOCChengJTeplyBA2006Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci USA1031663152016606824
   PubMed Web of Science ®Google Scholar
• FarokhzadOCJonSKhademhosseiniA2004Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cellsCancer Res642176687215520166
   PubMed Web of Science ®Google Scholar
• FerreiraCSMatthewsCSMissailidisS2006DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamersTumour Biol27628930117033199
   PubMedGoogle Scholar
• FreemanLMKrynyckyiBRLiY2002The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancerQ J Nucl Med462131712114876
   PubMedGoogle Scholar
• GhoshAHestonWD2004Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancerJ Cell Biochem9135283914755683
   PubMed Web of Science ®Google Scholar
• GinestierCCharafe-JauffretEBertucciF2002Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markersAm J Pathol161412233312368196
   PubMed Web of Science ®Google Scholar
• GinistyHSicardHRogerB1999Structure and functions of nucleolinJ Cell Sci112Pt 67617210036227
   PubMed Web of Science ®Google Scholar
• GoldLPoliskyBUhlenbeckO1995Diversity of oligonucleotide functionsAnnu Rev Biochem64763977574500
   PubMed Web of Science ®Google Scholar
• GoldenMCCollinsBDWillisMC2000Diagnostic potential of PhotoSELEX-evolved ssDNA aptamersJ Biotechnol812316778
   Web of Science ®Google Scholar
• GopinathSC2007Methods developed for SELEXAnal Bioanal Chem38711718217072603
   PubMed Web of Science ®Google Scholar
• GriffinLCTidmarshGFBockLC1993In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuitsBlood8112327168507864
   PubMed Web of Science ®Google Scholar
• HansfordJRMulliganLM2000Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesisJ Med Genet37118172711073534
   PubMed Web of Science ®Google Scholar
• HeldDMKisselJDPattersonJT2006HIV-1 inactivation by nucleic acid aptamersFront Biosci118911216146716
   PubMed Web of Science ®Google Scholar
• HickeBJMarionCChangYF2001Tenascin-C aptamers are generated using tumor cells and purified proteinJ Biol Chem27652486445411590140
   PubMed Web of Science ®Google Scholar
• HickeBJStephensAWGouldT2006Tumor targeting by an aptamerJ Nucl Med4746687816595502
   PubMed Web of Science ®Google Scholar
• HollingsworthMASwansonBJ2004Mucins in cancer: protection and control of the cell surfaceNat Rev Cancer41456014681689
   PubMed Web of Science ®Google Scholar
• HoroszewiczJSKawinskiEMurphyGP1987Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patientsAnticancer Res75B927352449118
   PubMed Web of Science ®Google Scholar
• HoughCDSherman-BaustCAPizerES2000Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancerCancer Res60226281711103784
   PubMed Web of Science ®Google Scholar
• HovanessianAGPuvion-DutilleulFNisoleS2000The cell-surface-expressed nucleolin is associated with the actin cytoskeletonExp Cell Res26123122811112338
   PubMed Web of Science ®Google Scholar
• HughesJARaoGA2005Targeted polymers for gene deliveryExpert Opin Drug Deliv211455716296741
   PubMedGoogle Scholar
• IresonCRKellandLR2006Discovery and development of anticancer aptamersMol Cancer Ther51229576217172400
   PubMed Web of Science ®Google Scholar
• IsraeliRSPowellCTCorrJG1994Expression of the prostate-specific membrane antigenCancer Res5471807117511053
   PubMed Web of Science ®Google Scholar
• IwashitaTKatoMMurakamiH1999Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinomaOncogene182639192210445857
   PubMed Web of Science ®Google Scholar
• JellinekDGreenLSBellC1995Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factorBiochemistry343611363727547864
   PubMed Web of Science ®Google Scholar
• JooEJten DamGBvan KuppeveltTH2005Nucleolin: acharan sulfate-binding protein on the surface of cancer cellsGlycobiology1511915329357
   PubMed Web of Science ®Google Scholar
• KatoYMinakawaNKomatsuY2005New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEXNucleic Acids Res33929425115914669
   PubMed Web of Science ®Google Scholar
• KohlgrafKGGawronAJHigashiM2003Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell lineCancer Res631650112012941828
   PubMed Web of Science ®Google Scholar
• KoukoulisGKGouldVEBhattacharyyaA1991Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implicationsHum Pathol227636431712747
   PubMed Web of Science ®Google Scholar
• LaberDASharmaVRBhupalamL2005Update on the first phase I study of AGRO100 in advanced cancerJ Clin Oncol (Meet Abstr)233064
   Web of Science ®Google Scholar
• LaberDATaftBSKloeckerGH2006Extended phase I study of AS1411 in renal and non-small cell lung cancersJ Clin Oncol24[18SJune 20 Supplement13098
   Google Scholar
• LapeyreBBourbonHAmalricF1987Nucleolin, the major nucleolar protein of growing eukaryotic cells: an unusual protein structure revealed by the nucleotide sequenceProc Natl Acad Sci USA846147263470736
   PubMed Web of Science ®Google Scholar
• LegrandDVigiéKSaidEA2004Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cellsEur J Biochem27123031714717698
   PubMedGoogle Scholar
• LuYLowPS2002Folate-mediated delivery of macromolecular anticancer therapeutic agentsAdv Drug Deliv Rev5456759312204598
   PubMed Web of Science ®Google Scholar
• LupoldSEHickeBJLinY2002Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigenCancer Res621440293312124337
   PubMed Web of Science ®Google Scholar
• MackieEJHalfterWLiveraniD1988Induction of tenascin in healing woundsJ Cell Biol1076 Pt 22757672462568
   PubMed Web of Science ®Google Scholar
• MaeshimaAMiyagiAHiraiT1997Mucin-producing adenocarcinoma of the lung, with special reference to goblet cell type adenocarcinoma: immunohistochemical observation and Ki-ras gene mutationPathol Int477454609234384
   PubMed Web of Science ®Google Scholar
• McCauleyTGKurzJCMerlinoPG2006Pharmacologic and pharmacokinetic assessment of anti-TGFbeta2 aptamers in rabbit plasma and aqueous humorPharm Res2323031116411148
   PubMed Web of Science ®Google Scholar
• McNamaraJO2ndAndrechekERWangY2006Cell type-specific delivery of siRNAs with aptamer-siRNA chimerasNat Biotechnol24810051516823371
   PubMed Web of Science ®Google Scholar
• MoffattSPapasakelariouCWiehleS2006Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugateGene Ther1397617216453011
   PubMed Web of Science ®Google Scholar
• MurphyGPElgamalAASuSL1998Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigenCancer83112259699840525
   PubMed Web of Science ®Google Scholar
• NgEWShimaDTCaliasP2006Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseNat Rev Drug Discov521233216518379
   PubMed Web of Science ®Google Scholar
• OhuchiSPOhtsuTNakamuraY2005A novel method to generate aptamers against recombinant targets displayed on the cell surfaceNucleic Acids Symp Ser (Oxf)493512
   PubMedGoogle Scholar
• OhuchiSPOhtsuTNakamuraY2006Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surfaceBiochimie88789790416540230
   PubMed Web of Science ®Google Scholar
• OosterkampHMScheinerLStefanovaMC1997Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z)Int J Cancer72187949212228
   PubMed Web of Science ®Google Scholar
• OrendG2005Potential oncogenic action of tenascin-C in tumorigenesisInt J Biochem Cell Biol37510668315743679
   PubMed Web of Science ®Google Scholar
• OrendGChiquet-EhrismannR2006Tenascin-C induced signaling in cancerCancer Lett24421436316632194
   PubMed Web of Science ®Google Scholar
• PegramMHsuSLewisG1999Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersOncogene181322415110327070
   PubMed Web of Science ®Google Scholar
• PerkinsACMissailidisS2007Radiolabelled aptamers for tumour imaging and therapyQ J Nucl Med Mol Imaging
   PubMedGoogle Scholar
• PestourieCTavitianBDucongeF2005Aptamers against extracellular targets for in vivo applicationsBiochimie879109213015733730
   PubMed Web of Science ®Google Scholar
• PietrasKOstmanASjoquistM2001Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumorsCancer Res61729293411306470
   PubMed Web of Science ®Google Scholar
• RusconiCPScardinoELayzerJ2002RNA aptamers as reversible antagonists of coagulation factor IXaNature419690290412214238
   PubMed Web of Science ®Google Scholar
• RusconiCPRobertsJDPitocGA2004Antidote-mediated control of an anticoagulant aptamer in vivoNat Biotechnol22111423815502817
   PubMed Web of Science ®Google Scholar
• SaidEAKrustBNisoleS2002The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptorJ Biol Chem277403749250212147681
   PubMed Web of Science ®Google Scholar
• SarcevicBLilischkisRSutherlandRL1997Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and Atype cyclin-CDK complexesJ Biol Chem2725233327379407125
   PubMed Web of Science ®Google Scholar
• SchmidtKSBorkowskiSKurreckJ2004Application of locked nucleic acids to improve aptamer in vivo stability and targeting functionNucleic Acids Res321957576515509871
   PubMed Web of Science ®Google Scholar
• SchneiderPMHungMCChioccaSM1989Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancerCancer Res49184968712569928
   PubMed Web of Science ®Google Scholar
• ShiHFanXSevilimeduA2007RNA aptamers directed to discrete functional sites on a single protein structural domainProc Natl Acad Sci USA104103742617360423
   PubMed Web of Science ®Google Scholar
• SlamonDJGodolphinWJonesLA1989Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancerScience2444905707122470152
   PubMed Web of Science ®Google Scholar
• SrivastavaMPollardHB1999Molecular dissection of nucleolin’s role in growth and cell proliferation: new insightsFaseb J131419112210544174
   PubMed Web of Science ®Google Scholar
• StefanidakisMKoivunenE2004Peptide-mediated delivery of therapeutic and imaging agents into mammalian cellsCurr Pharm Des102430334415379666
   PubMed Web of Science ®Google Scholar
• StorckSShuklaMDimitrovS2007Functions of the histone chaperone nucleolin in diseasesSubcell Biochem411254417484127
   PubMedGoogle Scholar
• SuSLHuangIPFairWR1995Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progressionCancer Res557144137882349
   PubMed Web of Science ®Google Scholar
• SullengerBAGallardoHFUngersGE1990Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replicationCell63360182225067
   PubMed Web of Science ®Google Scholar
• SullengerBAGallardoHFUngersGE1991Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivationJ Virol6512681161942253
   PubMed Web of Science ®Google Scholar
• Taylor-PapadimitriouJBurchellJMilesDW1999MUC1 and cancerBiochim Biophys Acta14552330113
   Web of Science ®Google Scholar
• TuerkCGoldL1990Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymeraseScience2494968505102200121
   PubMed Web of Science ®Google Scholar
• UmeharaTFukudaKNishikawaF2004Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3Nucleic Acids Symp Ser (Oxf)481956
   PubMedGoogle Scholar
• VaterAJaroschFBuchnerK2003Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEXNucleic Acids Res3121e13014576330
   PubMed Web of Science ®Google Scholar
• von Mensdorff-PouillySSnijdewintFGVerstraetenAA2000Human MUC1 mucin: a multifaceted glycoproteinInt J Biol Markers1543435611192832
   PubMed Web of Science ®Google Scholar
• WhiteRRSullengerBARusconiCP2000Developing aptamers into therapeuticsJ Clin Invest10689293411032851
   PubMed Web of Science ®Google Scholar
• WillisMCCollinsBDZhangT1998Liposome-anchored vascular endothelial growth factor aptamersBioconjug Chem95573829736491
   PubMed Web of Science ®Google Scholar
• YokotaJYamamotoTMiyajimaN1988Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologueOncogene2328373281095
   PubMed Web of Science ®Google Scholar
• ZagzagDFriedlanderDRMillerDC1995Tenascin expression in astrocytomas correlates with angiogenesisCancer Res554907147531617
   PubMed Web of Science ®Google Scholar
• ZhangSZhangHSReuterVE1998Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancersClin Cancer Res422953029516914
   PubMed Web of Science ®Google Scholar